Upadacitinib Interactions
There are 613 drugs known to interact with upadacitinib, along with 9 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 380 are major, 223 are moderate, and 10 are minor.
- View all 613 medications that may interact with upadacitinib
- View upadacitinib alcohol/food interactions (2)
- View upadacitinib disease interactions (9)
Most frequently checked interactions
View interaction reports for upadacitinib and the medicines listed below.
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- AndroGel (testosterone)
- Anoro Ellipta (umeclidinium / vilanterol)
- Aspir 81 (aspirin)
- Aspirin Low Strength (aspirin)
- Benylin Expectorant (dextromethorphan / guaifenesin)
- Benylin Multi-Symptom (diphenhydramine / pseudoephedrine)
- Brilinta (ticagrelor)
- Caltrate 600+D (calcium / vitamin d)
- Celebrex (celecoxib)
- Chantix (varenicline)
- Cialis (tadalafil)
- Concerta (methylphenidate)
- CoQ10 (ubiquinone)
- Creon (pancrelipase)
- Curcumin 95 (turmeric)
- D3 (cholecalciferol)
- Dexilant (dexlansoprazole)
- Dovonex (calcipotriene topical)
- Dramamine (dimenhydrinate)
- Drixoral Decongestant Non-Drowsy (pseudoephedrine)
- Efudex (fluorouracil topical)
- Ozempic (semaglutide)
- Paracetamol (acetaminophen)
- Pentasa (mesalamine)
- Plaquenil (hydroxychloroquine)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Upadacitinib alcohol/food interactions
There are 2 alcohol/food interactions with upadacitinib.
Upadacitinib disease interactions
There are 9 disease interactions with upadacitinib which include:
- cardiovascular risk
- malignancy
- thrombosis
- infections
- cytopenias
- gastrointestinal perforation
- hepatic impairment
- hyperlipidemia
- vaccination
Report options
More about upadacitinib
- upadacitinib consumer information
- Compare alternatives
- Reviews (238)
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antirheumatics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Rinvoq
Rinvoq (upadacitinib) is used to treat rheumatoid arthritis, psoriatic arthritis, atopic ...
Xeljanz
Xeljanz (tofacitinib) is an oral Janus kinase (JAK) inhibitor that may be used alone or with other ...
Entyvio
Entyvio (vedolizumab) is used to treat ulcerative colitis (UC) and Crohn's disease, reducing ...
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Omvoh
Omvoh is used to treat moderate to severe ulcerative colitis or Crohn's disease in adults. This ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Hydroxychloroquine
Hydroxychloroquine is a quinoline drug used to treat or prevent malaria. It's also used to treat ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
